10-Q Filing

SYNTEC OPTICS HOLDINGS, INC. CIK: 1866816 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001493152-21-031866`
Period End Date	20210930
Filing Date	20211217
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 21 Income Statement 5 Cash Flow Statement 13 Stockholders Equity 9

Balance Sheet 21 line items

Line Item	Tag	Value	Unit	Period
Cash on hand	`CashAndCashEquivalentsAtCarryingValue`	$528.90K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$528.90K	USD	Point-in-time
Deferred offering costs	`DeferredCosts`	$183.09K	USD	Point-in-time
Total assets	`Assets`	$712.00K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts payable and accrued offering costs	`AccountsPayableAndAccruedLiabilitiesCurrent`	$23.00K	USD	Point-in-time
Note payable- related party	`NotesPayableRelatedPartiesClassifiedCurrent`	$300.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Advances due - related party	`DueToOtherRelatedPartiesClassifiedCurrent`	$364.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$18.00	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$687.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$24.52K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	-	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	-	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$25.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$25.00K	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$712.00K	USD	Point-in-time

Income Statement 5 line items

Line Item	Tag	Value	Unit	Period
General and administrative expenses	`GeneralAndAdministrativeExpense`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	-	USD	Point-in-time
Net loss	`NetIncomeLoss`	-	USD	1 Quarter
Weighted average shares outstanding, basic and diluted (1)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.17M	shares	1 Quarter
Basic and diluted net loss per share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter

Cash Flow Statement 13 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	-	USD	Point-in-time
Net loss	`NetIncomeLoss`	-	USD	1 Quarter
Proceeds from issuance of Class B common stock to Sponsor	`ProceedsFromIssuanceOfCommonStock`	$25.00K	USD	1 Quarter
Proceeds from notes-payable to related party	`ProceedsFromRelatedPartyDebt`	$300.00K	USD	1 Quarter
Proceeds from advances from related party	`ProceedsFromAdvancesFromRelatedParty`	$364.00K	USD	1 Quarter
Payments of deferred offering costs associated with initial public offering	`PaymentsOfDeferredOfferingCostsAssociatedWithIntitalPublicOffering`	$160.09K	USD	1 Quarter
Net cash provided by financing activities:	`NetCashProvidedByUsedInFinancingActivities`	$528.90K	USD	1 Quarter
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$528.90K	USD	1 Quarter
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$528.90K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$528.90K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	-	USD	Point-in-time
Deferred offering costs included in accrued expenses	`DeferredOfferingCostsInludedInAccruedExpenses`	$23.00K	USD	1 Quarter

Stockholders Equity 9 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	-	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$25.00K	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$25.00K	USD	Point-in-time
Issuance of Class B common stock to Sponsor (1)	`StockIssuedDuringPeriodValueNewIssues`	$25.00K	USD	Point-in-time
Net loss	`NetIncomeLoss`	-	USD	Point-in-time
Net loss	`NetIncomeLoss`	-	USD	1 Quarter
Ending balance	`StockholdersEquity`	-	USD	Point-in-time
Ending balance	`StockholdersEquity`	$25.00K	USD	Point-in-time
Ending balance	`StockholdersEquity`	$25.00K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.